Using psychostimulants for treating residual symptoms in major depression.
Berlim
Marcelo T
MT
Depressive Disorders Program and McGill Group for Suicide Studies, Douglas Hospital Research Centre, McGill University, Montré, Que.
Turecki
Md Gustavo
MG
D000328:Adult; D018687:Antidepressive Agents, Second-Generation / Q000627:therapeutic use; D001559:Benzhydryl Compounds / Q000627:therapeutic use; D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D003511:Cyclohexanols / Q000627:therapeutic use; D003865:Major Depressive Disorder / Q000188:drug therapy* / Q000523:psychology*; D005260:Female; D006801:Humans; D000077408:Modafinil; D011569:Psychiatric Status Rating Scales; D016032:Randomized Controlled Trials as Topic; D000069470:Venlafaxine Hydrochloride
D018687:Antidepressive Agents, Second-Generation; D001559:Benzhydryl Compounds; D000697:Central Nervous System Stimulants; D003511:Cyclohexanols; D000069470:Venlafaxine Hydrochloride; D000077408:Modafinil